Navigation Links
Statement from the Consumer Healthcare Products Association on Mississippi Bill that Seeks to Make Cold, Allergy Medicines Containing Pseudoephedrine Prescription-Only
Date:1/28/2010

Majority of Mississippi voters support e-tracking as better solution

WASHINGTON, Jan. 28 /PRNewswire-USNewswire/ -- The following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA):

"Today, the Mississippi House of Representatives passed a bill without listening to any testimony that, if it becomes law, will greatly limit how cold and allergy sufferers access some of their medicines. The legislation would require law-abiding families to obtain a doctor's prescription for pseudoephedrine- (PSE-) containing medicines rather than simply asking for these medications at the pharmacy or service counter. Mississippi lawmakers seem prepared to impose this burden on Mississippians, even though there is a better solution.

"Mississippi's voters agree this is not the right way to address meth. As states continually find themselves in dire financial situations, policy makers must balance efforts to regulate ingredients used to create meth with the public health and economic consequences of restricting access to important cold and allergy medications. Electronic tracking is one such solution that eight other states have adopted to fight domestic meth production while maintaining consumer over-the-counter access to these products.

"An e-tracking system is a tool that law enforcement and pharmacists can put in place to stop the sale of illegal amounts of PSE as set forth by the Combat Meth Act. With this real-time tracking system, states can also link up with other states to track cross-border sales. For instance, neighboring Louisiana has plans to implement e-tracking starting in March. Additionally, e-tracking would be implemented at no cost to the state; the makers of PSE-containing products would purchase and maintain the system for Mississippi.

"A CHPA-sponsored survey conducted by David Binder Research this month* found that almost two-thirds of Mississippi voters surveyed (N=350) feel making common cold and allergy medications containing pseudoephedrine available by prescription only would be a big mistake, placing a heavy and unnecessary new burden on law-abiding people, significantly increasing consumer costs, and hurting the state's own finances at the worst possible time.

"Among other findings:

  • 61 percent of those surveyed would oppose laws that would require these medications be sold only by prescription.
  • 74 percent of those surveyed agree that an Rx-only requirement would create an 'unnecessary burden' for law-abiding citizens.
  • And 59 percent of those surveyed indicate they feel the legislative train is speeding forward too fast, agreeing 'before my state's lawmakers enact a new law, they should study the economic impact and societal burden a prescription law would pose.'

"This House bill was passed before hearing any testimony or listening to the concerns of constituents. We  urge the state legislature to assess the deep burdens of this bill and the proven alternative of e-tracking before placing such serious and costly restriction on law-abiding Mississippians. "

CHPA is the 129-year-old-trade association representing U.S. manufacturers and distributors of over-the- counter medicines and nutritional supplements.

www.chpa-info.org

SOURCE Consumer Healthcare Products Association

RELATED LINKS
http://www.chpa-info.org

'/>"/>

SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from RC Cancer Centers Regarding News Story on Radiation Oncology
2. Statement From the American Health Care Association and National Center for Assisted Living in Anticipation of President Obamas State of the Union Address
3. SEIU-UHW Statement on Kaiser Union Election in Southern California
4. Operation Rescues Advisory Board Issues Statement on Mr. Terrys Extremism
5. Statement: Helping the UN Help Haiti
6. Pelosi Statement on New Report That Health Reform Will Create 4 Million More Jobs Over the Next Decade
7. Statement by Blue Shield of California CEO Bruce Bodaken Regarding the Groundbreaking for the Family Violence Prevention Funds International Center
8. Statement of US Secretary of Labor Hilda L. Solis on December 2009 employment numbers
9. FRC Statement on the Christmas Eve Passage of the Health Care Reform Bill
10. Statement from Larry Minnix, CEO, American Association of Homes and Services for the Aging On the Senates Passage of Health Reform Legislation
11. PhRMA Statement on Senate Health Care Reform Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Chicago, Illinois (PRWEB) , ... January 17, 2017 , ... ... Antonio Breast Cancer Symposium (SABCS) or those who desire a more intimate review and ... Antonio: Breast Cancer – Bench to Bedside—is being offered by Imedex on February 4, ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Healthful-Flex. , The company, owned and operated by Ed Stroup, was created ... reasonable price with the highest level of customer service. Healthful Balance products can ...
(Date:1/17/2017)... ... , ... Kevin Harrington (one of the original Sharks from mega-hit reality series ... topic of Beauty and Personal Care. , Everyone makes New Year’s ... commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro will ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro Development Group has ... high speed technology into the fabric of an entire community. A highlight of ... and wellness in a yet-to-be-named, health focused campus. Leading this initiative in partnership ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Mirror Mirror ... earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, ... part of this elite group of providers. , Produced by Zeltiq, CoolSculpting is ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global fluoropolymer market in the healthcare industry ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, ... from industry experts. The report covers the market landscape and its ...
(Date:1/17/2017)... --  Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, today ... and pharmaceutical development at Tocagen, will present at Phacilitate Cell ... in Miami . Details of ... ... viruses - what to do when and why Date and Time: ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), ... report to their offering. ... The global active pharmaceutical ingredients market is expected to ... 2016, growing at a CAGR of 6.3% from 2016 to 2021. ...
Breaking Medicine Technology: